IFNG and neoplasm: Preclinical models consistently demonstrate post-HIFU up-regulation of pro-inflammatory cytokines (e.g., IFN-γ, TNF-α) and recruitment of tumor-specific cytotoxic T lymphocytes, culminating in systemic anti-tumor immunity [27].